Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

By sjmartinez • December 30, 2025

Bloomfield GS, Watanabe M, McCallum S, Aberg JA, Awwad A, Campbell TB, Cespedes MS, Chu SM, Currier JS, Diggs MR, Sponseller CA, Fichtenbaum CJ, Lu MT, Malvestutto CD, Pierone G, Rhame F, Tuan J, Zhao S, Zanni MV, Grinspoon SK, Ribaudo HJ, Douglas PS. Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Circ Heart Fail. 2025 Dec 29:e013382. doi: 10.1161/CIRCHEARTFAILURE.125.013382. Epub ahead of print. PMID: 41457980.

Tags: cardiovascular disease, cell count, heart failure, Hypertension, Infectious Diseases, Obesity, Publications

Immunotherapy for invasive Candida infections: Translating host-directed strategies into clinical practice

Sprute R, Singh S, Conti HR, Cornely OA, van de Veerdonk FL, Carvalho A, Ibrahim AS. Immunotherapy for invasive Candida infections: Translating host-directed strategies into[...]

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

Hoffman R, Watanabe M, Martínez E, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Lu[...]

PREVALENCE AND SEVERITY OF STEATOTIC LIVER DISEASE IN WOMEN WITH AND WITHOUT HIV

Duarte MJ, Tien PC, Kuniholm MH, Ma Y, Thio CL, Hanna DB, Witt MD, Skvarca C, Brock J, French AL, Alcaide M, Floris-Moore M, Seaberg[...]